FDA approves second monoclonal antibody treatment for early Alzheimer’s disease
By
Kristen Fischer
Jul 02, 2024
The US Food and Drug Administration (FDA) approved a second monoclonal antibody treatment for for early Alzheimer’s on Tuesday. Eli Lilly’s Kisunla (donanemab), which has proven to slow the disease...
New criteria for diagnosing, staging Alzheimer’s stirs controversy
By
Kristen Fischer
Jul 01, 2024
The Alzheimer’s Association set out new criteria for diagnosing and staging Alzheimer’s based on recent advancements, especially biomarkers that can biologically detect the disease instead of relying...
Is Mom late on bills? Could be sign of dementia, report finds
By
Kristen Fischer
Jun 05, 2024
Older adults who fall behind on paying their bills may have early signs of dementia and be susceptible to further financial risks, according to a recent report.
Study spots brain clusters linked to subjective memory complaints
By
Kristen Fischer
May 23, 2024
People with subjective memory complaints include two subgroups, and being in the lower performance cluster increased the risk for cognitive impairment, according to a study published Thursday in Alzheimer’s...
CMS shares new coverage details for Alzheimer’s drug Leqembi
By
Alicia Lasek
Jun 26, 2023
On the eve of an FDA decision, CMS has released new information about the detailed patient data that clinicians must provide to ensure Medicare coverage when prescribing Leqembi.
Our simple, revolutionary tool to understanding those living with dementia
By
Angie Frantz
Aug 01, 2022
I recently had the honor of attending the Alzheimer’s Disease International (ADI) 2022 Global Conference in London, England, where I presented a memory care initiative that we’ve been rolling out across...
Older adults who volunteered more often had better emotional well-being, were less likely to have Alzheimer’s disease and had lower risks for not being able to perform activities of daily living.
Report: During pandemic, Alzheimer’s discharges to home health, home rise, while those to nursing homes...
By
Kristen Fischer
Mar 29, 2024
A new study pinpoints how the COVID-19 pandemic affected the post-hospital discharge settings for people with Alzheimer’s disease and related dementias (ADRDs). Discharges to nursing homes fell, while...
Study: Having two copies of gene mutation linked to Alzheimer’s may cause onset
By
Kristen Fischer
May 07, 2024
A new study finds that possessing two copies of a specific gene mutation that’s common in Alzheimer’s disease may be the cause behind the disease in those people.
Shifts in cholesterol, triglycerides could raise risk for Alzheimer’s
By
Kristen Fischer
Jul 10, 2023
Older people with levels of cholesterol and triglycerides that go up and down a lot may be at an increased risk for Alzheimer’s disease and dementias compared to people whose levels are steady.